The Insight Partners published latest research report on “GMP Cytokines Market Size Report, Share, Trends, Growth & Forecast to 2027 - COVID-19 Impact and Global Analysis By Type, and Application, and Geography”, the global market size is expected to reach USD 158.13 million in 2027 from USD 84.72 million in 2019. The market is estimated to grow with a CAGR of 8.1% from 2020 to 2027.
The Insight Partners published latest research report on “GMP Cytokines Market Size Report, Share, Trends, Growth & Forecast to 2027 - COVID-19 Impact and Global Analysis By Type, and Application, and Geography”, the global market size is expected to reach USD 158.13 million in 2027 from USD 84.72 million in 2019. The market is estimated to grow with a CAGR of 8.1% from 2020 to 2027.
Request Sample PDF Brochure: https://www.theinsightpartners.com/sample/TIPRE00008212
Growth Strategies by the Key Players Operating in the GMP Cytokines Market:
Apr 2020 - Proteintech Group, Inc. received ISO 13485 Certification for Its HumanKine Human Cell-expressed Cytokines and Growth Factors.
Oct 2020 - Akron Biotech acquired Cytiva, a global life sciences leader. This acquisition is expected to help Akron Biotech enhance its cGMP-compliant solutions to support advanced therapy development. The installation of FlexFactory will enable the company to ease constraints in the supply of critical materials for cell and gene therapy manufacturing
Oct 2020 - CellGenix has reconstructed and expanded its production facility for cytokines and implemented a state-of-the-art automated filling and freeze-drying line.
Jun 2019 - Proteintech Group, Inc. started its brand new state-of-the-art Good Manufacturing Practice (GMP)-grade laboratory, and it is located at the company’s headquarters in Rosemont, IL.
GMP cytokines are used in cell and gene therapy for expansion and differentiation of various cell types, ex vivo cultures and other therapeutic approaches. Moreover, these are also used in various tissue engineered products for clinical applications. Additionally, extensive research is being conducted on cytokines to discover new therapeutic approaches to treat chronic conditions.
Directly Purchase Premium Copy of GMP Cytokines Market Growth Report (2020-2027) at: https://www.theinsightpartners.com/buy/TIPRE00008212
Global GMP Cytokines Market Share Report, Segmentations, Regional & Country Scope:
| Report Coverage | Details |
| Market Size Value in | USD 84.72 Million in 2019 |
| Market Size Value by | USD 158.13 Million by 2027 |
| Growth rate | CAGR of 8.1% from 2020-2027 |
| Forecast Period | 2020-2027 |
| Base Year | 2020 |
| No. of Pages | 145 |
| No. of Tables | 56 |
| No. of Charts & Figures | 68 |
| Historical data available | Yes |
| Segments covered | Type, and Application, and Geography |
| Regional scope | North America; Europe; Asia Pacific; Latin America; MEA |
| Country scope | US, UK, Canada, Germany, France, Italy, Australia, Russia, China, Japan, South Korea, Saudi Arabia, Brazil, Argentina |
| Report coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Companies Covered | Miltenyi Biotec, Sino Biological Inc., ABCAM, PeproTech Inc., Akron Biotech, CellGenix GmbH, BIO-TECHNE CORPORATION, CREATIVE BIOARRAY, Proteintech Group Inc., REPROCELL Inc |
| Key Research Capabilities | Global Market Assessment, Business Development Strategies, Competitive Landscape, Opportunity Analysis, Regional and Country Level Market Analysis, Market Entry Strategies, Market Dynamics, Risk and Return Assessments, Pricing Analysis, Market Size and Forecasting, Company Profiling, Value Chain Analysis, Expansion Strategies, SWOT Analysis, New Product Development |
Browse key market insights spread across 145 pages with 56 list of tables & 68 list of figures from the report, “GMP Cytokines Market Growth & Forecast to 2027 - COVID-19 Impact and Global Analysis By Type (TNF, Interleukins, Growth Factors, and Others), and Application (Cell and Gene Therapy, Tissue- Engineered Products, and Others), and Geography” in detail along with the table of contents: https://www.theinsightpartners.com/reports/gmp-cytokines-market
Geographically, the GMP cytokines market is segmented into North America, Europe, Asia Pacific, the Middle East and Africa, and South and Central America. North America held the largest market share in 2019. In North America, the US is the largest market for GMP cytokines. The growth of the market in the region is attributed to the presence of key market players and their product development. In addition, the escalating prevalence of chronic conditions is further contributing to the growth of the market in North America.
Biomarkers are used to refine diagnosis, comprehend the progress of diseases, and monitor the efficiency of treatment based on physiological, anatomical, and molecular parameters associated with the severity of specific disease states. Cytokines can also be used as biomarkers for some of the autoimmune disorders. Moreover, the involvement of market players for the development and research on cytokines biomarkers is expected to offer market growth in years to come. For instance, in March 2020, Evelo Biosciences, Inc., a clinical stage biotechnology company, announced results of its cytokines candidate EDP1815 as a biomarker for inflammatory diseases, such as psoriasis. Additionally, in September 2020, Sonnet BioTherapeutics Holdings, Inc. announced positive results of its IL-12 candidate, SON-1010 for the efficacy over cancer. Moreover, the drug can also be used as biomarker for cancer. Further, in May 2020, Cerecor Inc. and Myriad Genetics Inc. announced results of collaborative study about CERC-002 cytokines as biomarkers for acute respiratory distress syndrome during COVID-19. All these developments are likely to reshape the GMP cytokines market during the forecast period.
Stem cell research has been widely investigated globally to improve the quality of human health. The stem cells play a prominent role in replacement and reconstruction of damaged tissues. Based on extensive research on stem cells, many scientists have appealed that the cells could probably generate novel therapies for various chronic diseases, such as cardiovascular disease and cancers. With the advent of new technologies and research, the cytokines growth factor is also contributing to the utilization of stem cells for novel therapeutics. Hematopoietic stem cell therapy cytokines (growth factors) play a major role in the regulation of multiple parameters of hematopoietic stem cells, such as self-renewal, quiescence, apoptosis, differentiation, and mobilization. Moreover, the growth factors are also responsible for cooperative actions of several other growth factors and other hormones for binding of receptors on these cells. Hematopoietic stem cells are currently used for treating more than 80 medical diseases, which include diseases of the immune system, blood disorders, metabolic disorders, neurological disorders, genetic disorders, and several types of cancers, including leukemia and lymphoma. Further, extensively increasing number of product launches for the stem cell therapies is further extended to boost the market growth. For instance, in December 2019, CEVEC and CellGenix announced launch of GMP TGF-ß1 for the cell and gene therapy industry. Such product launches are anticipated to boost the growth of the GMP cytokines market during the forecast period.
The World Health Organization, National Health Service, Centers for Disease Control and Prevention, King Abdullah International Medical Research Center, and Japanese Society of Molecular Cell Biology of Macrophages, along with company websites, are the major primary and secondary sources referred to while preparing this report.
Go through further research published by The Insight Partners: (Purchase with 10% Instant Discount):
Cytokine Market Forecast to 2028 - Covid-19 Impact and Global Analysis
Interleukin Inhibitors Market Forecast to 2028 - Covid-19 Impact and Global Analysis
Gene Therapy Market Forecast to 2028 - COVID-19 Impact and Global Analysis
Cell and Gene Therapy Market Forecast to 2028 - COVID-19 Impact and Global Analysis
Gene Therapy For Rare Disease Market Forecast to 2028 - Covid-19 Impact and Global Analysis
About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
Contact Us:
If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Sameer Joshi
E-mail: sales@theinsightpartners.com
Phone: +1-646-491-9876
Press Release: https://www.theinsightpartners.com/pr/gmp-cytokines-market